Medios AG (ILM1) is a Medical equipment services company in the Healthcare sector, listed on Deutsche Borse Xetra. This page provides the complete earnings calendar, dividend schedule, and financial data for Medios AG in 2026. The next earnings report is expected on November 10, 2026.
Next earnings date
10 Nov 2026
In 81 days
EPS estimate
0.25
Revenue estimate
624.7M
Past earnings
Latest earnings analysis
Met consensus on revenue: Medios AG posted USD 625.05 million, 0.1% above the USD 624.71 million estimate, while EPS was not reported against a USD 0.2542 estimate. In the previous report both EPS and revenue came in ahead of expectations.
No dividend history available.
Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.
Medios AG (ILM1) is scheduled to report earnings on November 10, 2026.
Medios AG (ILM1) last reported earnings on August 12, 2026.
Medios AG (ILM1) is listed on Deutsche Borse Xetra.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.